Business Description
Onward Medical NV
ISIN : NL0015000HT4
Compare
Compare
Traded in other countries / regions
ONWD.Belgium63E.GermanyONWRF.USAONWDb.UK IPO Date
2021-10-25Description
Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injuries. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United States and four European markets: Germany, France, the UK, and the Netherlands to create a customer base.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.85 | |||||
| Equity-to-Asset | 0.39 | |||||
| Debt-to-Equity | 0.94 | |||||
| Debt-to-EBITDA | -0.51 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 24.3 | |||||
| 3-Year EPS without NRI Growth Rate | 29.3 | |||||
| 3-Year FCF Growth Rate | 21.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 8.14 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | 8.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.65 | |||||
| Quick Ratio | 3.65 | |||||
| Cash Ratio | 3.36 | |||||
| Days Payable | 1557.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -72.3 | |||||
| Shareholder Yield % | -10.07 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -149.47 | |||||
| ROA % | -70.53 | |||||
| ROIC % | -269.31 | |||||
| ROC (Joel Greenblatt) % | -1776.58 | |||||
| ROCE % | -82.73 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 9.23 | |||||
| Price-to-Tangible-Book | 20.4 | |||||
| EV-to-EBIT | -5.62 | |||||
| EV-to-EBITDA | -5.78 | |||||
| EV-to-FCF | -7.06 | |||||
| Price-to-Net-Current-Asset-Value | 26.61 | |||||
| Price-to-Net-Cash | 47.08 | |||||
| Earnings Yield (Greenblatt) % | -17.77 | |||||
| FCF Yield % | -13.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Onward Medical NV Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -1.09 | ||
| Beta | 0 | ||
| Volatility % | 8.13 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0.000007 | ||
| 20-Day SMA (€) | 6.12 | ||
| 12-1 Month Momentum % | 8.13 | ||
| 52-Week Range (€) | 5.66 - 6.12 | ||
| Shares Outstanding (Mil) | 44.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Onward Medical NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Onward Medical NV Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Onward Medical NV Frequently Asked Questions
What is Onward Medical NV(CHIX:ONWDb)'s stock price today?
The current price of CHIX:ONWDb is €6.12. The 52 week high of CHIX:ONWDb is €6.12 and 52 week low is €5.66.
When is next earnings date of Onward Medical NV(CHIX:ONWDb)?
The next earnings date of Onward Medical NV(CHIX:ONWDb) is .
Does Onward Medical NV(CHIX:ONWDb) pay dividends? If so, how much?
Onward Medical NV(CHIX:ONWDb) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers